18718666

Source:http://linkedlifedata.com/resource/pubmed/id/18718666

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0035820, umls-concept:C0154830, umls-concept:C0378516, umls-concept:C1749467
pubmed:issue	11
pubmed:dateCreated	2008-12-10
pubmed:abstractText	To determine the vitreous level of soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in patients with proliferative diabetic retinopathy (PDR) or idiopathic macular hole (MH). Furthermore, to investigate the relationships among sVEGFR-1, vascular endothelial growth factor (VEGF), and pigment epithelium-derived factor (PEDF).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7802443
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Eye Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Nerve Growth Factors, http://linkedlifedata.com/resource/pubmed/chemical/Serpins, http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor..., http://linkedlifedata.com/resource/pubmed/chemical/pigment epithelium-derived factor
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1549-4713
pubmed:author	pubmed-author:ChikaraishiYuichiY, pubmed-author:IzutaHiroshiH, pubmed-author:MatsumuraMiyoM, pubmed-author:MatsunagaNozomuN, pubmed-author:OgataNahokoN, pubmed-author:ShimazawaMasamitsuM, pubmed-author:SummersLinda CLC
pubmed:issnType	Electronic
pubmed:volume	115
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1916-22
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:18718666-Aged, pubmed-meshheading:18718666-Angiogenesis Inhibitors, pubmed-meshheading:18718666-Case-Control Studies, pubmed-meshheading:18718666-Coculture Techniques, pubmed-meshheading:18718666-Diabetic Retinopathy, pubmed-meshheading:18718666-Dose-Response Relationship, Drug, pubmed-meshheading:18718666-Endothelium, Vascular, pubmed-meshheading:18718666-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:18718666-Eye Proteins, pubmed-meshheading:18718666-Female, pubmed-meshheading:18718666-Fibroblasts, pubmed-meshheading:18718666-Humans, pubmed-meshheading:18718666-Male, pubmed-meshheading:18718666-Middle Aged, pubmed-meshheading:18718666-Neovascularization, Pathologic, pubmed-meshheading:18718666-Nerve Growth Factors, pubmed-meshheading:18718666-Retinal Perforations, pubmed-meshheading:18718666-Retrospective Studies, pubmed-meshheading:18718666-Serpins, pubmed-meshheading:18718666-Umbilical Veins, pubmed-meshheading:18718666-Vascular Endothelial Growth Factor A, pubmed-meshheading:18718666-Vascular Endothelial Growth Factor Receptor-1, pubmed-meshheading:18718666-Vitreous Body
pubmed:year	2008
pubmed:articleTitle	Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
pubmed:affiliation	Department of Biofunctional Evaluation, Molecular Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
pubmed:publicationType	Journal Article